March 16, 2016
  • Anti-Hypertension Therapy Risky for Diabetics With Lower Blood Pressure

    Because of their increased risk for cardiovascular disease, diabetes patients are often targeted for intensified antihypertension treatment. But when, according to a new study, does beneficial treatment become too much and risky?

  • Stroke a Concern if HRT Worsens Migraines in Women

    Amid all of the other controversies and conflicting information on hormone replacement therapy for postmenopausal women, there’s another concern: Worsening migraines could indicate a higher risk of stroke. Here is more information.

  • Bill Seeks to Limit Medicare Drug Abusers to One Pharmacy, Prescriber
    The ability to go “pharmacy shopping” makes it easier for drug abusers to get drugs. Now, new bipartisan congressional legislation is seeking to limit Medicare patients with a history of drug problems to one pharmacist and one prescriber. Find out how that would work.
  • Benefits of New Sexual Desire Drug Called
    ‘Marginal’ or Worse

    Last year, the FDA approved a new drug to treat low sexual desire in premenopausal women. Find out why a new study and commentary question the approval of flibanserin, claiming it has few benefits and a large number of adverse effects.


Connect With U.S. Pharmacist
USP Google AppUSP Itunes App